ipamorelin is a selective ghrelin-receptor (GHS-R1a) agonist
Limited insurance coverage and affordability issues create barriers to widespread patient access, particularly in lower-income populations and countries with stringent pricing regulations
Li K, Gong Q, Xiang XD, Guo G, Liu J, Zhao L, Li J, Chen N, Li H, Zhang LJ, et al
BPC-157 is used in non-clinical research involving cellmatrix interaction models, angiogenic pathway studies, and investigations into structural protein activity within controlled experimental systems
The plaintiffs were Cardone Ventures, LLC, and 10X Health Ventures, LLC, the latter of which was co-founded by Brecka and Workinger
However, it is rapidly degraded by dipeptidyl peptidase-4 (DPP-IV) and other serum proteases, giving it a half-life of only 10-20 minutes